Blue water vaccines reports year 2022 financial results and recent business highlights

Cincinnati, march 09, 2023 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or the “company”), today announced its financial results for the fiscal year ended december 31, 2022 and provided an update on recent business developments and company progress. blue water vaccines is a preclinical stage biotechnology company developing vaccines against multiple infectious diseases, including acute otitis media (“aom”) and pneumonia from streptococcus pneumoniae colonization, influenza, norovirus, rotavirus, monkeypox, marburg virus disease and chlamydia.
BWV Ratings Summary
BWV Quant Ranking